Oliver Scherf‐Clavel

1.1k total citations
61 papers, 771 citations indexed

About

Oliver Scherf‐Clavel is a scholar working on Oncology, Molecular Biology and Genetics. According to data from OpenAlex, Oliver Scherf‐Clavel has authored 61 papers receiving a total of 771 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 9 papers in Molecular Biology and 9 papers in Genetics. Recurrent topics in Oliver Scherf‐Clavel's work include Analytical Chemistry and Chromatography (8 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Methods in Pharmaceuticals (7 papers). Oliver Scherf‐Clavel is often cited by papers focused on Analytical Chemistry and Chromatography (8 papers), Drug Transport and Resistance Mechanisms (8 papers) and Analytical Methods in Pharmaceuticals (7 papers). Oliver Scherf‐Clavel collaborates with scholars based in Germany, Netherlands and Australia. Oliver Scherf‐Clavel's co-authors include Fritz Sörgel, Martina Kinzig, Ulrike Holzgrabe, Max Kurlbaum, Charlotte Kloft, Ulrich Jaehde, Alwin D. R. Huitema, Neeltje Steeghs, Stefanie L. Groenland and Wilhelm Huisinga and has published in prestigious journals such as SHILAP Revista de lepidopterología, Analytical Chemistry and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Oliver Scherf‐Clavel

54 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Scherf‐Clavel Germany 16 176 149 111 94 89 61 771
David de Graaf United States 11 394 2.2× 240 1.6× 55 0.5× 98 1.0× 45 0.5× 15 1.0k
Jaroslav Chládek Czechia 22 188 1.1× 155 1.0× 63 0.6× 148 1.6× 150 1.7× 66 1.2k
Cristina Sottani Italy 26 374 2.1× 426 2.9× 56 0.5× 95 1.0× 108 1.2× 64 1.8k
M Hroch Czechia 20 198 1.1× 259 1.7× 62 0.6× 113 1.2× 56 0.6× 70 1.0k
Raffaele Di Francia Italy 20 337 1.9× 363 2.4× 86 0.8× 59 0.6× 103 1.2× 66 1.1k
Ronald Miller United States 3 308 1.8× 267 1.8× 28 0.3× 58 0.6× 116 1.3× 8 1.4k
Estelle Marrer Switzerland 11 236 1.3× 83 0.6× 18 0.2× 74 0.8× 90 1.0× 13 885
Qixing Zhu China 18 277 1.6× 74 0.5× 45 0.4× 45 0.5× 96 1.1× 85 1.1k

Countries citing papers authored by Oliver Scherf‐Clavel

Since Specialization
Citations

This map shows the geographic impact of Oliver Scherf‐Clavel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Scherf‐Clavel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Scherf‐Clavel more than expected).

Fields of papers citing papers by Oliver Scherf‐Clavel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Scherf‐Clavel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Scherf‐Clavel. The network helps show where Oliver Scherf‐Clavel may publish in the future.

Co-authorship network of co-authors of Oliver Scherf‐Clavel

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Scherf‐Clavel. A scholar is included among the top collaborators of Oliver Scherf‐Clavel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Scherf‐Clavel. Oliver Scherf‐Clavel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Buschmann, Helmut, et al.. (2024). Application of advanced high resolution mass spectrometric techniques for the analysis of losartan potassium regarding known and unknown impurities. Journal of Pharmaceutical and Biomedical Analysis. 240. 115955–115955. 6 indexed citations
3.
Buschmann, Helmut, et al.. (2024). Prediction of Degradation Profiles for Various Sartans under Solvent-Free Mechanochemical Conditions. Analytical Chemistry. 96(32). 13166–13173. 1 indexed citations
4.
Ziebuhr, Wilma, et al.. (2024). Structure Elucidation of the Daptomycin Products Generated upon Heterologous Expression of the Daptomycin Resistance Gene Cluster drcAB. ACS Infectious Diseases. 10(12). 4271–4278. 2 indexed citations
5.
Chen, Chunli, Max Taubert, Martina Kinzig, et al.. (2024). Understanding adefovir pharmacokinetics as a component of a transporter phenotyping cocktail. European Journal of Clinical Pharmacology. 80(7). 1069–1078.
6.
Ziebuhr, Wilma, et al.. (2023). Development, validation and application of a selective and sensitive LC-MS/MS method for the quantification of daptomycin in a suspension of Mammaliicoccus sciuri in Mueller-Hinton broth. Journal of Pharmaceutical and Biomedical Analysis. 227. 115293–115293. 4 indexed citations
7.
Galli, Bruno, et al.. (2023). Harnessing Bile for Drug Absorption through Rational Excipient Selection. Molecular Pharmaceutics. 20(8). 3864–3875. 1 indexed citations
8.
9.
Ziebuhr, Wilma, et al.. (2023). The solvent- and surface-dependent adsorption of the lipopeptide antibiotic daptomycin: The general necessity of adsorption tests. Journal of Pharmaceutical and Biomedical Analysis. 235. 115657–115657.
10.
Müller, Tobias, Thomas Dandekar, Oliver Scherf‐Clavel, et al.. (2022). Targeted metabolic profiling of urinary steroids with a focus on analytical accuracy and sample stability. SHILAP Revista de lepidopterología. 25. 44–52. 9 indexed citations
11.
Nuss, Katja, Peter Kronen, Marcus Gutmann, et al.. (2022). Oral Use of Therapeutic Carbon Monoxide for Anyone, Anywhere, and Anytime. ACS Biomaterials Science & Engineering. 9(6). 2937–2948. 3 indexed citations
12.
Isberner, Nora, Anja Gesierich, Bastian Schilling, et al.. (2022). Monitoring of Dabrafenib and Trametinib in Serum and Self-Sampled Capillary Blood in Patients with BRAFV600-Mutant Melanoma. Cancers. 14(19). 4566–4566. 5 indexed citations
13.
Groenland, Stefanie L., Alwin D. R. Huitema, Neeltje Steeghs, et al.. (2021). Developing a Nationwide Infrastructure for Therapeutic Drug Monitoring of Targeted Oral Anticancer Drugs: The ON-TARGET Study Protocol. Cancers. 13(24). 6281–6281. 14 indexed citations
14.
15.
Scherf‐Clavel, Oliver, Elke Schaeffeler, Max Taubert, et al.. (2019). A Clinical Drug‐Drug Interaction Study Assessing a Novel Drug Transporter Phenotyping Cocktail With Adefovir, Sitagliptin, Metformin, Pitavastatin, and Digoxin. Clinical Pharmacology & Therapeutics. 106(6). 1398–1407. 28 indexed citations
16.
Scherf‐Clavel, Oliver, et al.. (2019). A HILIC-MS/MS assay for the quantification of metformin and sitagliptin in human plasma and urine: A tool for studying drug transporter perturbation. Journal of Pharmaceutical and Biomedical Analysis. 175. 112754–112754. 18 indexed citations
17.
Kurlbaum, Max, et al.. (2019). A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring. Analytical and Bioanalytical Chemistry. 411(17). 3951–3962. 16 indexed citations
18.
Favaloro, Emmanuel J., Soma Mohammed, & Oliver Scherf‐Clavel. (2017). The increasing maturity of the von Willebrand factor collagen binding in von Willebrand disease diagnosis. Haemophilia. 24(1). 20–23. 9 indexed citations
19.
Rees, J. S., S. M. Jenkins, P. M. H. Dummer, et al.. (2007). An initial evaluation of virtual reality simulation in teaching pre-clinical operative dentistry in a UK setting.. PubMed. 15(2). 89–92. 18 indexed citations
20.
Scherf‐Clavel, Oliver & PJ Rees. (1997). INHALER USE IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE. International Journal of Clinical Practice. 51(7). 443–445. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David de Graaf Breakdown of academic impact, for papers by Jaroslav Chládek Breakdown of academic impact, for papers by Cristina Sottani Breakdown of academic impact, for papers by M Hroch Breakdown of academic impact, for papers by Raffaele Di Francia Breakdown of academic impact, for papers by Ronald Miller Breakdown of academic impact, for papers by Estelle Marrer Breakdown of academic impact, for papers by Qixing Zhu
Rankless by CCL
2026